DE69918711D1 - Amphiphile polyamin verbindungen - Google Patents

Amphiphile polyamin verbindungen

Info

Publication number
DE69918711D1
DE69918711D1 DE69918711T DE69918711T DE69918711D1 DE 69918711 D1 DE69918711 D1 DE 69918711D1 DE 69918711 T DE69918711 T DE 69918711T DE 69918711 T DE69918711 T DE 69918711T DE 69918711 D1 DE69918711 D1 DE 69918711D1
Authority
DE
Germany
Prior art keywords
amphiphile
polyamine compounds
compounds
polynucleotides
polypeptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69918711T
Other languages
English (en)
Other versions
DE69918711T2 (de
Inventor
L Felgner
Xiang Gao
Jing Ling
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gene Therapy Systems
Original Assignee
Gene Therapy Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gene Therapy Systems filed Critical Gene Therapy Systems
Application granted granted Critical
Publication of DE69918711D1 publication Critical patent/DE69918711D1/de
Publication of DE69918711T2 publication Critical patent/DE69918711T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/20Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/06Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
    • C07C217/14Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring
    • C07C217/18Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
    • C07C217/22Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by carbon atoms having at least two bonds to oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/22Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/16Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • C07C311/19Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/50Compounds containing any of the groups, X being a hetero atom, Y being any atom
    • C07C311/52Y being a hetero atom
    • C07C311/64X and Y being nitrogen atoms, e.g. N-sulfonylguanidine
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Polyamides (AREA)
DE69918711T 1998-11-25 1999-11-24 Amphiphile polyamin verbindungen Expired - Fee Related DE69918711T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US11002098P 1998-11-25 1998-11-25
US110020P 1998-11-25
US11107898P 1998-12-04 1998-12-04
US111078P 1998-12-04
PCT/US1999/027737 WO2000031022A1 (en) 1998-11-25 1999-11-24 Amphiphilic polyamine compounds

Publications (2)

Publication Number Publication Date
DE69918711D1 true DE69918711D1 (de) 2004-08-19
DE69918711T2 DE69918711T2 (de) 2005-07-21

Family

ID=26807625

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69918711T Expired - Fee Related DE69918711T2 (de) 1998-11-25 1999-11-24 Amphiphile polyamin verbindungen

Country Status (8)

Country Link
US (2) US6348499B1 (de)
EP (1) EP1133465B1 (de)
JP (1) JP2002530364A (de)
AT (1) ATE271032T1 (de)
AU (1) AU1828100A (de)
CA (1) CA2352279A1 (de)
DE (1) DE69918711T2 (de)
WO (1) WO2000031022A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1830200A (en) 1998-11-25 2000-06-13 Vanderbilt University Cationic liposomes for gene transfer
AU2102101A (en) * 1999-12-17 2001-06-25 Gene Therapy Systems, Inc. Use of cationic lipids for intracellular protein delivery
TW200303304A (en) 2002-02-18 2003-09-01 Astrazeneca Ab Chemical compounds
US20080299095A1 (en) * 2004-07-09 2008-12-04 Bc Cancer Agency Nup98-Hox Fusions for Expansion of Hemopoietic Stem Cells
WO2008102247A2 (en) * 2007-02-23 2008-08-28 University Of The Witwatersrand, Johannesburg A polyamide rate-modulated monolithic drug delivery system
GB0724253D0 (en) * 2007-12-12 2008-01-30 Fermentas Uab Transfection reagent
GB0915796D0 (en) 2009-09-09 2009-10-07 Fermentas Uab Polymerase compositions and uses
US9856456B2 (en) 2009-10-12 2018-01-02 Thermo Fisher Scientific Baltics Uab Delivery agent
GB0917792D0 (en) * 2009-10-12 2009-11-25 Fermentas Uab Delivery agent

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4897355A (en) 1985-01-07 1990-01-30 Syntex (U.S.A.) Inc. N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
US5264618A (en) * 1990-04-19 1993-11-23 Vical, Inc. Cationic lipids for intracellular delivery of biologically active molecules
FR2665705B1 (fr) * 1990-08-09 1993-07-30 Atta Nouveaux derives fluores amphiphiles a structure telomere, leur procede de preparation et leur utilisation dans des preparations a usage biomedical.

Also Published As

Publication number Publication date
DE69918711T2 (de) 2005-07-21
EP1133465A1 (de) 2001-09-19
WO2000031022A1 (en) 2000-06-02
EP1133465B1 (de) 2004-07-14
US6433017B1 (en) 2002-08-13
AU1828100A (en) 2000-06-13
JP2002530364A (ja) 2002-09-17
US6348499B1 (en) 2002-02-19
CA2352279A1 (en) 2000-06-02
ATE271032T1 (de) 2004-07-15

Similar Documents

Publication Publication Date Title
DZ3191A1 (fr) Composés d'indazole et compositions pharmaceutiques inhibant les protéines kinases, et procédés d'utilisation de ceux-ci.
NO20012915D0 (no) Ny farmasöytisk formulering
DE69909015D1 (de) Polymere Zusammensetzungen mit kontrollierter Wirkstoffabgabe
ATE231872T1 (de) Thiazolopyrimidinderivate
HUP0004310A3 (en) Cyclic amino acids, and derivatives thereof and pharmaceutical compositions comprising the said compounds as active agents
DE69822209D1 (de) ESTRON-SULFatase HEMMENDE ESTRON-SULFAMATVERBINDUNGEN, PHARMAZEUTISCHE ZUSAMMENSETZUNGEN UND VERWENDUNGEN DAVON
DK0960107T3 (da) 6-Thiosubstituerede paclitaxeler
DZ2964A1 (fr) Diphénylurées substituées nouvelles, et compositions pharmaceutiques les contenant.
TR200100054T2 (tr) Paroksetin metansülfonat
ATE329897T1 (de) Verbindungen und zusammensetzungen zur verabreichung aktiven substanzen
PT1140939E (pt) 2-aril-3-(heteroaril)- imidazo [1,2-alfa] pirimidinas substituidas, e formulacoes farmaceuticas e metodos relacionados
DE69606028D1 (de) Taxal derivate, deren herstellung und diese enthaltende pharmazeutische zusammensetzung
BR9804500B1 (pt) derivado de amida, referida composição farmacêutica e agente terapêutico.
NO992339D0 (no) Farmas°ytiske formuleringer
TR200003787A3 (tr) Kararli yavas salimli oral dozaj bilesimi.
BR9607851B1 (pt) combinaÇço e formulaÇço farmacÊutica.
TR199800631A3 (tr) Ecza formülasyonu.
NO20006138L (no) Substituerte indolinoner, fremstilling og anvendelse derav som medikamenter
DE69928140D1 (de) Antipicornavirale Verbindungen, deren Herstellung und Verwendung
PT1169460E (pt) Preparacao de moleculas biologicamente activas.
IS5662A (is) Þíenýlasólýlalkoxýetanamín, framleiðsla þeirra ognotkun sem lyf
BR0014465B1 (pt) 1,1'-bifenil-2-carbonamidas 2'-substituÍdas, preparado farmacÊutico e aplicaÇÕes dos referidos compostos.
DE60045402D1 (de) Silylalkylplatin (IV) Verbindungen und deren Herstellung
DZ2700A1 (fr) Indoles 2,3-substitués servant d'agents anti-inflammatoires et analgésiques.
ZA200007415B (en) Amino acid derivatives and drugs containing the same as the active ingredient.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee